Back to top
more

Labcorp (LH)

(Real Time Quote from BATS)

$235.65 USD

235.65
54,256

+1.27 (0.54%)

Updated Nov 7, 2024 11:10 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

Zacks News

Zacks.com featured highlights include: Laboratory Corporation of America, SpartanNash Company, B&G Foods, QIAGEN and Rent-A-Center

Zacks.com featured highlights include: Laboratory Corporation of America, SpartanNash Company, B&G Foods, QIAGEN and Rent-A-Center

Here's Why You Should Retain Integer Holdings Stock for Now

Integer Holdings (ITGR) continues to gain traction from solid presence in the broader MedTech space and portfolio management.

    Allscripts Extends Strategic Partnership With Microsoft

    Allscripts (MDRX) extends partnership with Microsoft that can help transform healthcare with smarter technology, thereby improving patient outcomes.

      Here's Why You Should Retain Luminex (LMNX) Stock for Now

      Luminex (LMNX) continues to benefit from robust product portfolio, solid molecular diagnostics and ARIES platforms.

      BD Collaborates With BARDA to Combat Coronavirus Crisis

      Becton, Dickinson (BDX) forms a strategic public-private partnership with BARDA to help the U.S. government in its efforts to fight the COVID-19 pandemic and future pandemics.

      5 Stocks Trading Near 52-Week High That Can Scale Higher

      Investors target stocks that display a bullish run. Stocks seeing price strength have a high chance of carrying the momentum forward.

      Henry Schein Banks on Dental Consumable Amid Coronavirus Woes

      Henry Schein (HSIC) seems upbeat about its dental technology business, Henry Schein One.

      Henry Schein Medical to Expand in Telemedicine With VisualDx

      Henry Schein's (HSIC) VisualDx system to be integrated with Medpod's technology infrastructure for improved patient outcome.

      QIAGEN (QGEN) Reports Encouraging Preliminary Q2 Results

      Preliminary net revenues for second-quarter 2020 improved 18-19% at CER.

      Baxter Gets FDA Nod for Altapore Shape Bioactive Bone Graft

      Baxter (BAX) receives FDA approval for Altapore Shape that will provide surgeons versatile options to advance the art of healing and boost clinical outcomes during a surgery.

      Hologic Expands Product Portfolio With New Ultrasound System

      Hologic's (HOLX) latest cart-based ultrasound system enhances efficiency and accuracy to better meet the requirements of breast imagers and optimize patient care.

      Here's Why You Should Hold on to Nevro (NVRO) Stock Now

      Investor confidence is high on Nevro (NVRO), thanks to solid prospects

      Medtronic's LINQ II ICM Gets Multiple Regulatory Approvals

      Medtronic's (MDT) FDA and CE Mark-approved LINQ II ICM enables physicians to optimize device settings via remote programming, without requiring patients' in-office visits.

      Trina Mukherjee headshot

      3 GARP MedTech Stocks to Beat Pandemic-Led Market Volatility

      Here we look at three stocks that investors can add to their watchlist backed by robust long-term prospects.

      Medtronic Launches User-Friendly Insulin Infusion Set in US

      Medtronic's (MDT) MiniMed Mio Advance infusion set, is aimed at providing optimal user experience to insulin pump-using diabetic patients.

      LabCorp Launches At-Home Coronavirus Test Collection Kit

      LabCorp (LH) claims this to be the first digital COVID-19 service that physicians can use to remotely diagnose patients before any surgery or procedure.

      BD Receives EUA for New Antigen Test to Combat COVID-19

      Becton, Dickinson (BDX) receives EUA from the FDA for a rapid, point-of-care, antigen test to detect SARS-CoV-2 in 15 minutes.

      BD Unveils BD PurPrep Patient Preoperative Skin Preparation

      By developing fully sterile PurPrep, BD (BDX) is offering health care experts a more complete set of tools to mitigate the risk of intrinsic contamination in antiseptic solutions.

      Here's Why You Should Retain Avanos Medical Stock for Now

      Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

      Myriad Genetics, OptraHEALTH Partner to Offer Cancer Knowledge

      Myriad Genetics (MYGN) collaborates with OptraHEALTH to provide an AI-powered cognitive ChatBOT to serve as a genetic health knowledge platform to prospective hereditary cancer patients.

      LH or ALGN: Which Is the Better Value Stock Right Now?

      LH vs. ALGN: Which Stock Is the Better Value Option?

      Align Technology's Rollouts Aid Amid Procedural Deferrals

      Align Technology's (ALGN) new virtual solutions ensure continuity of care amid pandemic.

      Thermo Fisher Stock Rises on Solid Q2 Growth Expectation

      Thermo Fisher (TMO) provides encouraging Q2 guidance for organic growth.

      Myriad Genetics Rides on EndoPredict Amid Coronavirus Crisis

      Myriad Genetics (MYGN) expects to register an uptick in hereditary cancer volumes on account of its contract with UnitedHealthcare.

      Pharmaceutical Wholesale to Aid Walgreens' (WBA) Q3 Earnings?

      Walgreen Boots' (WBA) international businesses in the third quarter is likely to have suffered a huge blow with international trade coming almost to a standstill.